Published 4 days ago • loading... • Updated 4 days ago

Spruce Bio sows the seeds of its new future

Summary by Pharmaphorum

Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug.

1 Articles

All

Left

Center

Right

Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug.

4 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated4 days agoBias Distribution

100% Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Pharmaphorum broke the news in 4 days ago on Thursday, April 17, 2025.

Sources are mostly out of (0)